Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents
- PMID: 36369166
- PMCID: PMC9652805
- DOI: 10.1186/s13065-022-00887-x
Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents
Abstract
Herein, we reported the synthesis of nineteen novel 1,2,4-triazole derivatives including 1,3-diphenyl-2-(1H-1,2,4-triazol-1-yl) propan-1-ones (7a-e), 1-(1,3-diphenylpropan-2-yl)-1H-1,2,4-triazole (8a-c) and 1,4-diphenyl-2-(1H-1,2,4-triazol-1-yl) butane-1,4-diones (10a-k). The structures of these derivatives were confirmed by spectroscopic techniques like IR, 1H-NMR, Mass spectroscopy and Elemental analysis. The cytotoxic activities of the synthesized compounds were evaluated against three human cancer cell lines including MCF-7, Hela and A549 using MTT assay. Compounds 7d, 7e, 10a and 10d showed a promising cytotoxic activity lower than 12 μM against Hela cell line. The safety of these compounds was also, evaluated on MRC-5 as a normal cell line and relieved that most of the synthesized compounds have proper selectivity against normal and cytotoxic cancerous cell lines. Finally, molecular docking studies were also, done to understand the mechanism and binding modes of these derivatives in the binding pocket of aromatase enzyme as a possible target.
Keywords: 1,2,4-Triazole; ADME; Anticancer; MTT assay; Molecular docking.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures







Similar articles
-
Design and synthesis of novel (Z)-5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-3-((1-substituted phenyl-1H-1,2,3-triazol-4-yl)methyl)thiazolidine-2,4-diones: a potential cytotoxic scaffolds and their molecular modeling studies.Mol Divers. 2021 Nov;25(4):2017-2033. doi: 10.1007/s11030-020-10093-3. Epub 2020 May 2. Mol Divers. 2021. PMID: 32361888
-
Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.Chem Biodivers. 2022 Jun;19(6):e202100754. doi: 10.1002/cbdv.202100754. Epub 2022 Apr 28. Chem Biodivers. 2022. PMID: 35427437
-
Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.Daru. 2014 Dec 24;22(1):83. doi: 10.1186/s40199-014-0083-4. Daru. 2014. PMID: 25539909 Free PMC article.
-
Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents.BMC Chem. 2022 Nov 22;16(1):100. doi: 10.1186/s13065-022-00893-z. BMC Chem. 2022. PMID: 36419100 Free PMC article.
-
Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.Med Chem. 2020;16(6):750-760. doi: 10.2174/1573406415666190620144404. Med Chem. 2020. PMID: 31218963
Cited by
-
Search for New Compounds with Anti-Inflammatory Activity Among 1,2,4-Triazole Derivatives.Molecules. 2024 Dec 21;29(24):6036. doi: 10.3390/molecules29246036. Molecules. 2024. PMID: 39770124 Free PMC article. Review.
-
Direct Synthesis of Formamide from CO2 and H2O with Nickel-Iron Nitride Heterostructures under Mild Hydrothermal Conditions.J Am Chem Soc. 2023 Sep 13;145(36):19768-19779. doi: 10.1021/jacs.3c05412. Epub 2023 Aug 29. J Am Chem Soc. 2023. PMID: 37642297 Free PMC article.
-
Application of Novel Triazolium-Containing Hydrogels to Cotton Fabrics: Evaluation of Their Flame Retardancy and Antibacterial Properties.ACS Omega. 2025 May 23;10(21):21486-21498. doi: 10.1021/acsomega.5c00281. eCollection 2025 Jun 3. ACS Omega. 2025. PMID: 40488028 Free PMC article.
-
Design and synthesis of novel multi-target tetrabromophthalimides as CBS and Topo-II inhibitors and DNA intercalators.RSC Med Chem. 2024 Aug 30;15(11):3800-16. doi: 10.1039/d4md00585f. Online ahead of print. RSC Med Chem. 2024. PMID: 39290384 Free PMC article.
-
Dual α-amylase and α-glucosidase inhibition by 1,2,4-triazole derivatives for diabetes treatment.Sci Rep. 2025 Jul 25;15(1):27172. doi: 10.1038/s41598-025-11214-4. Sci Rep. 2025. PMID: 40715234 Free PMC article.
References
-
- Labib MB, Philoppes JN, Lamie PF, Ahmed ER. Azole-hydrazone derivatives: design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents. Bioorg Chem. 2018;76:67–80. - PubMed
-
- Narsimha S, Nukala SK, Savitha Jyostna T, Ravinder M, Srinivasa Rao M, Vasudeva RN. One-pot synthesis and biological evaluation of novel 4-[3-fluoro-4-(morpholin-4-yl)] phenyl-1 H-1, 2, 3-triazole derivatives as potent antibacterial and anticancer agents. J Heterocycl Chem. 2020;57(4):1655–1665.
-
- Grytsai O, Valiashko O, Penco-Campillo M, Dufies M, Hagege A, Demange L, et al. Synthesis and biological evaluation of 3-amino-1, 2, 4-triazole derivatives as potential anticancer compounds. Bioorg Chem. 2020;104:104271. - PubMed
-
- Gaber AA, Bayoumi AH, El-Morsy AM, Sherbiny FF, Mehany AB, Eissa IH. Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers. Bioorg Chem. 2018;80:375–395. - PubMed
LinkOut - more resources
Full Text Sources